Human umbilical cord mesenchymal stem cells regulate immunoglobulin a secretion and remodel the diversification of intestinal microbiota to improve colitis

BACKGROUND: Mesenchymal stem cell (MSC) therapy has emerged as a promising novel therapeutic strategy for managing inflammatory bowel disease (IBD) mainly via dampening inflammation, regulating immune disorders, and promoting mucosal tissue repair. However, in the process, the associated changes in...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Airu, Wang, Xing, Liang, Xiaonan, Wang, Wenxin, Li, Chenyang, Qian, Jiaming, Zhang, Xiaolan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478446/
https://www.ncbi.nlm.nih.gov/pubmed/36118029
http://dx.doi.org/10.3389/fcimb.2022.960208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478446/
https://www.ncbi.nlm.nih.gov/pubmed/36118029
http://dx.doi.org/10.3389/fcimb.2022.960208

Ejemplares similares